MoonLake Immunotherapeutics

Market Cap: Small Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: KY61559X1045

USD

18.02

1.15 (6.82%)

Mar 25

NAS

View all stocks in this country

Company CV

About MoonLake Immunotherapeutics

stock-summary

MoonLake Immunotherapeutics

Pharmaceuticals & Biotechnology

Helix Acquisition Corp is a blank check company. The Company is incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The Company is primarily focused on the healthcare industry.

Company Coordinates

Company Details

C/O Cormorant Asset Management, Llp, 200 Clarendon Street Fl 52 BOSTON MA : 02116

stock-summary

Tel: 1 857 7020370

stock-summary

stock-summary

Registrar Details

Shareholding

Shareholding Snapshot

Shareholding Compare (%holding)

Majority shareholders

Domestic Funds

Domestic Funds

Held in 40 Schemes (15.4%)

Foreign Institutions

Held by 94 Foreign Institutions (5.97%)

Strategic Entities with highest holding

Highest Public shareholder

Board of Directors

Management

Designation

No Data

Stock DNA

Revenue and Profits:

Net Sales:

(Quarterly Results - Dec 2025)

Net Profit:

-63 Million

Industry

Pharmaceuticals & Biotechnology

Market cap

USD 1,200 Million (Small Cap)

P/E

NA (Loss Making)

Industry P/E

NA

Dividend Yield

0.00%

Debt Equity

-1.06

Return on Equity

-73.97%

Price to Book

4.15